NIH VideoCast - The changing epidemiology of HPV and cervical cancer: from etiology, to validation of prevention methods, to dissemination

Skip Navigation

The changing epidemiology of HPV and cervical cancer: from etiology, to validation of prevention methods, to dissemination

Loading... Loading video...

353 Views

Air date:	Wednesday, May 3, 2017, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 353 (138 Live, 215 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	00:53:13
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director's Wednesday Afternoon Lecture Series Over three decades of studies moving from etiology to preventive methods research to guidelines development, Dr. Schiffman has learned some broad lessons about the strengths and weaknesses of epidemiology that he will describe. He joined the Clinical Genetics Branch in October 2009 to study intensively why HPV is such a powerful carcinogenic exposure, akin to an acquired genetic trait with high penetrance for a cancer phenotype. The main studies in which Dr. Schiffman played a major role in the past 5 years, listed chronologically, include: The Portland Kaiser Cohort; the Taiwan Cohort Study; the Guanacaste Natural History Study; the ASCUS-LSIL Triage Study (ALTS); the Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED/Biopsy); the Costa Rica Vaccine Trial (CVT); the Persistence and Progression (PaP) Study; and Nigeria Project Itoju. These studies overall have related HPV status to outcome for more than 100,000 women. For more information go to https://oir.nih.gov/wals/2016-2017/changing-epidemiology-hpv-cervical-cancer-etiology-validation-prevention

NLM Title:	The changing epidemiology of HPV and cervical cancer : from etiology, to validation of prevention methods, to dissemination / Mark Schiffman.
Author:	Schiffman, Mark. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director's Wednesday Afternoon Lecture Series Over three decades of studies moving from etiology to preventive methods research to guidelines development, Dr. Schiffman has learned some broad lessons about the strengths and weaknesses of epidemiology that he will describe. He joined the Clinical Genetics Branch in October 2009 to study intensively why HPV is such a powerful carcinogenic exposure, akin to an acquired genetic trait with high penetrance for a cancer phenotype. The main studies in which Dr. Schiffman played a major role in the past 5 years, listed chronologically, include: The Portland Kaiser Cohort; the Taiwan Cohort Study; the Guanacaste Natural History Study; the ASCUS-LSIL Triage Study (ALTS); the Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED/Biopsy); the Costa Rica Vaccine Trial (CVT); the Persistence and Progression (PaP) Study; and Nigeria Project Itoju. These studies overall have related HPV status to outcome for more than 100,000 women.
Subjects:	Epidemiologic Studies Papillomaviridae--pathogenicity Uterine Cervical Neoplasms--epidemiology Uterine Cervical Neoplasms--genetics
Publication Types:	Lecture Webcast

NLM Classification:	WP 480
NLM ID:	101706984
CIT Live ID:	23318
Permanent link:	https://videocast.nih.gov/watch=23318

Related Videos...